SAEN
Genenta Science S.p.A.
SAEN | NASDAQ
$0.65
-$0.05 (-7.14%)
At close: Nov 5, 2026, 4:00 PM ET
$0.67
+$0.02 (+2.46%)
After-hours:
Nov 5, 2026, 4:52 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 26.97K | 46.51K | 41.71K | 6K | 5.1K | 1.77K |
Gross Profit | -26.97K | -46.51K | -41.71K | -6K | -5.1K | -1.77K |
Operating Income | -6.34M | -10.2M | -11.53M | -10.79M | -5.93M | -5.2M |
Interest Income | 968.7K | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -6.27M | -9.31M | -11.44M | -8.28M | -5.76M | -5.2M |
Net Income | -6.27M | -9.31M | -11.44M | -8.28M | -5.76M | -5.2M |
Selling & General & Admin | 3.72M | 5.13M | 5.12M | 5.57M | 2.39M | 837.35K |
Research & Development | 2.59M | 5.03M | 6.36M | 5.21M | 3.53M | 4.36M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 6.32M | 10.15M | 11.48M | 10.78M | 5.92M | 5.2M |
Interest Expense | 384.21K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 6.34M | 10.2M | 11.53M | 10.79M | 5.93M | 5.2M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 19.71M | 18.27M | 18.22M | 18.22M | 18.22M | 18.12M |
Shares Outstanding (Diluted) | 19.71M | 18.27M | 18.22M | 18.22M | 18.22M | 18.12M |
EPS (Basic) | -0.33 | -0.49 | -0.64 | -0.47 | -0.31 | -0.31 |
EPS (Diluted) | -0.33 | -0.49 | -0.64 | -0.47 | -0.31 | -0.31 |
EBITDA | -5.86M | -9.27M | -11.4M | -8.27M | -5.76M | -5.2M |
EBIT | -5.89M | -9.31M | -11.44M | -8.28M | -5.76M | -5.2M |
Depreciation & Amortization | 28.08K | 44.52K | 42.45K | 6.14K | 4.89K | 1.9K |
Add to Watchlist
Select watchlists to add or remove SAEN